Related Experiment Video
Updated: Aug 20, 2026

06:34
An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
Published on: December 1, 2017
Protective effectiveness of hantavirus vaccine
Keeho Park1, Chang Soo Kim, Ki-Tae Moon
1National Cancer Center, Goyang, Republic of Korea. bachism@empal.com
Emerging Infectious Diseases
|January 25, 2005
Abstract:
A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.

